CD8A and neoplasm: Based on the results presented here and our previous work (7), we propose a model whereby circulating PD-1+ tumor–specific CD8 T cells reach the tumor site where they are stimulated by DCs, proliferate, acquire Trm markers to be retained locally, and become terminally exhausted.